Schick test control

January 2005
Taber's Cyclopedic Medical Dictionary;2005, p1951
Reference Entry
A definition of the term "Schick test control" is presented. It refers to the inactivated diphtheria toxin for the Schick test, which is used in the Schick test as a control.


Related Articles

  • Schick test.  // Taber's Cyclopedic Medical Dictionary;2005, p1951 

    A definition of the term "Schick test" is presented. It refers to a test to determine the degree of immunity to diphtheria. The test involves an intradermal injection of 0.1 ml of dilute diphtheria toxin. A negative test result with little or no reaction is the indication of presence of...

  • Schick test control.  // Taber's Cyclopedic Medical Dictionary;2005, p1951 

    A definition of the term "Schick test control" is presented. It refers to the inactivated diphtheria toxin for the Schick test, which is used in the Schick test as a control.

  • diphtheria toxin for Schick test.  // Taber's Cyclopedic Medical Dictionary;2005, p605 

    A definition of the medical term "diphtheria toxin for Schick test" is presented, which refers to the toxin used for determining immunity to diphtheria.

  • Enzyme immunoassay of immune complexes formed in vitro via interactions of serum antibodies with diphtheria toxin. Titova, N.; Sviridov, V. // Applied Biochemistry & Microbiology;Mar2005, Vol. 41 Issue 2, p205 

    The interaction of diphtheria toxin with serum antitoxin antibodies has been studied by enzyme immunoassay at variable ratios of the original amounts of the antigen and antibodies in the reaction mixture. Under the conditions of excess of the antibodies, the free toxin was not detected, and free...

  • Application of fermentor technology in production of diphtheria toxin. Moghadam, Ahmad Taghavi; Afsharpad, Koroush // Jundishapur Journal of Microbiology;2008, Vol. 1 Issue 1, p24 

    The present study shows the production of diphtheria toxoid in fermentor as compared to old static method of production. With using 45l glass fermentor which has the provision for growth of the organisms under controlled conditions with regard to temperature, pH, aeration and addition of maltose...

  • Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors. Michl, P.; Gress, T. M. // Current Cancer Drug Targets;Nov2004, Vol. 4 Issue 8, p689 

    Patients with advanced solid tumors frequently relapse and succumb to their metastatic disease after developing resistance to conventional treatment modalities such as chemotherapy and radiotherapy. In these patients, novel strategies of targeting widespread tumors are urgently needed. The...

  • Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding. Hamaoka, Miki; Chinen, Ichino; Murata, Takuya; Takashima, Seiji; Iwamoto, Ryo; Mekada, Eisuke // Journal of Biochemistry;Jul2010, Vol. 148 Issue 1, p55 

    HB-EGF is a member of the EGF family of growth factors that bind and activate the EGF receptor. HB-EGF is synthesized as a membrane-anchored protein (proHB-EGF), and then proteolytically cleaved, resulting in the mitogenically active soluble form. ProHB-EGF functions as the receptor for the...

  • pH-Triggered Conformational Switching along the Membrane Insertion Pathway of the Diphtheria Toxin T-Domain. Ladokhin, Alexey S. // Toxins;Aug2013, Vol. 5 Issue 8, p1362 

    The translocation (T)-domain plays a key role in the action of diphtheria toxin and is responsible for transferring the catalytic domain across the endosomal membrane into the cytosol in response to acidification. Deciphering the molecular mechanism of pH-dependent refolding and membrane...

  • A fold-back single-chain diabody format enhances the bioactivity of an anti-monkey CD3 recombinant diphtheria toxin-based immunotoxin. Geun-Bae Kim; Zhirui Wang; Yuan Yi Liu; Scott Stavrou; Askale Mathias; K.Jeanine Goodwin; Judith M. Thomas; David M. Neville // PEDS: Protein Engineering, Design & Selection;Sep2007, Vol. 20 Issue 9, p425 

    T-cell depleting anti-CD3 immunotoxins have utility in non-human primate models of transplantation tolerance and autoimmune disease therapy. We recently reported that an affinity matured single-chain (scFv) anti-monkey CD3 antibody, C207, had increased binding to T-cells and increased...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics